Anuh Pharma

Anuh Pharma EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Anuh Pharma (ANUHPHR.NS) as of Oct 16, 2026 is 546.94 M INR. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 703.64 M INR — a change of -22.27% (lower).

EBITDA

546.94 MINR

YoY

-22.27%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Anuh Pharma is 2026 546.94 M INR. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Anuh Pharma was 2025 703.64 M INR. It decreases by -22.27% lower compared to the previous year.

The Anuh Pharma EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
341.74 M INR
Jan 1, 2020
301.19 M INR
Jan 1, 2021
445.88 M INR
Jan 1, 2022
520.43 M INR
Jan 1, 2023
573.89 M INR
Jan 1, 2024
872.47 M INR
Jan 1, 2025
703.64 M INR
Jan 1, 2026
546.94 M INR
The Anuh Pharma EBITDA history
YEAREBITDAYoY
546.94 MINR-22.27%
703.64 MINR-19.35%
872.47 MINR+52.03%
573.89 MINR+10.27%
520.43 MINR+16.72%
445.88 MINR+48.04%
301.19 MINR-11.87%
341.74 MINR+69.67%
201.41 MINR-8.86%
220.99 MINR-43.80%
393.21 MINR+19.34%
329.49 MINR+23.08%
267.70 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Anuh Pharma Stock analysis

What does Anuh Pharma do? Anuh Pharma Ltd is a pharmaceutical company based in Mumbai, India, operating within the healthcare sector. The company, which went public on April 19, 1995, employs 159 full-time staff. It specializes in the manufacturing of active pharmaceutical ingredients (APIs), focusing on various therapeutic categories including Macrolides, Anti-TB, Anti-Bacterials, Anti-Malarial, Anti-Hypertension, Expectorant, and Corticosteroids. The company produces specific products such as Erythromycin variants including Erythromycin Ethyl Succinate, Erythromycin Stearate, Erythromycin Estolate, Erythromycin Propionate, Erythromycin Phosphate, Erythromycin 11,12 Carbonate, and Azithromycin under its Macrolides segment. Anti-TB products include Pyrazinamide and Isoniazid. Anti-Malarial products consist of Sulfadoxine and Pyrimethamine. Anti-Bacterials include Chloramphenicol and Chloramphenicol Palmitate. Anti-Hypertension products feature Losartan Potassium, Telmisartan, and Atorvastatin Calcium. The company also manufactures Ambroxol Hydrochloride as an Expectorant and Moxifloxacin Hydrochloride under Quinolones. Anuh Pharma Ltd maintains a corporate website at https://www.anuhpharma.com/ for further information about its operations and products. Anuh Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Anuh Pharma stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Anuh Pharma is 546.94 M INR in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Anuh Pharma changed from 703.64 M INR to 546.94 M INR, representing a -22.27% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Anuh Pharma since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Anuh Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Anuh Pharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Anuh Pharma